Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (688)	11/3/1997 11:06:00 PM
From: Charles Holewinski	Respond to of 1115

I have waited so long for something to pop on LIDAK that it will take a whole lot more that 4 to satisfy me. Does anyone know what the financials are with the manfacturing and marketing agreements LIDAK signed with several companies, especially Bristol Myers? If LIDAK is only going to get a small piece of the pie, assuming LIDACOL is approved, then it probably won't be worthwhile waiting for the price to go much beyond where it is now. Maybe only to 4 to 6 range. But if the payout is 30 to 50% or more then that is a different story. Charlie